Save the New Antibiotic Cefiderocol for Salvage Therapy

Cefiderocol (Fetroja, fet-ROH-jah) will be a new IV cephalosporin for multidrug-resistant (MDR) gram-negative infections.

It doesn't fall into a cephalosporin "generation." But think of it like ceftazidime or cefepime with an extended side chain.

This gives cefiderocol broad in vitro coverage for many types of carbapenem-resistant Enterobacteriaceae (CRE)...and resistant Pseudomonas, Acinetobacter, and Stenotrophomonas.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals